Back to Defilade Capital Management, L.P.
Defilade Capital Management, L.P.
Q3 2026 13F filing
Updated 6 days ago30 disclosed positions worth $598.8M
Portfolio value
$598.8M
Total holdings
30
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PFIZER INC | $43.5M | 1.52M | 7.26% | — |
| 2 | L ELI LILLY & CO | $40.2M | 34.8K | 6.72% | — |
| 3 | B BIOMARIN PHARMACEUTICAL INC | $36.1M | 601.9K | 6.03% | — |
| 4 | G GILEAD SCIENCES INC | $33.8M | 226.6K | 5.64% | — |
| 5 | A AXSOME THERAPEUTICS INC. | $32.3M | 175.4K | 5.40% | — |
| 6 | A AMGEN INC | $31.2M | 74.1K | 5.21% | — |
| 7 | O ORIC PHARMACEUTICALS INC | $30.6M | 2.27M | 5.11% | — |
| 8 | A ASCENDIS PHARMA A/S | $29.4M | 128.9K | 4.90% | — |
| 9 | I INTUITIVE SURGICAL INC | $29.2M | 71.9K | 4.88% | — |
| 10 | S STRYKER CORPORATION | $22.5M | 81.5K | 3.75% | — |
| 11 | V VERA THERAPEUTICS INC | $21.1M | 652.4K | 3.52% | — |
| 12 | C COGENT BIOSCIENCES INC | $20.2M | 631.6K | 3.38% | — |
| 13 | V VEEVA SYS INC | $19.7M | 69.1K | 3.30% | — |
| 14 | R ROYALTY PHARMA PLC | $19.4M | 332.2K | 3.24% | — |
| 15 | M AGIOS PHARMACEUTICALS INC | $19M | 570.3K | 3.17% | — |
| 16 | T THERMO FISHER SCIENTIFIC INC | $17.9M | 26.5K | 2.98% | — |
| 17 | O OCULAR THERAPEUTIX INC | $17.5M | 2.28M | 2.91% | — |
| 18 | L LARIMAR THERAPEUTICS INC | $15.8M | 4.93M | 2.63% | — |
| 19 | B BOSTON SCIENTIFIC CORP | $15.3M | 350.8K | 2.56% | — |
| 20 | R REVOLUTION MEDICINES INC | $14.6M | 71.2K | 2.44% | — |
| 21 | S SOLVENTUM CORP | $14.6M | 165.7K | 2.44% | — |
| 22 | N ENVISTA HOLDINGS CORPORATION | $12.5M | 534.4K | 2.09% | — |
| 23 | O OLEMA PHARMACEUTICALS INC | $12.4M | 1.44M | 2.08% | — |
| 24 | E EVOMMUNE INC | $11.8M | 1.43M | 1.97% | — |
| 25 | E ELEDON PHARMACEUTICALS INC | $8.9M | 3.53M | 1.49% | — |
| 26 | I ICU MED INC | $8.7M | 54.4K | 1.46% | — |
| 27 | E ENOVIS CORPORATION | $7.3M | 399.7K | 1.22% | — |
| 28 | P PACS GROUP INC | $6.9M | 165.0K | 1.14% | — |
| 29 | B BLACK DIAMOND THERAPEUTICS I | $3.3M | 1.77M | 0.56% | — |
| 30 | M MEREO BIOPHARMA GROUP PLC | $3M | 7.56M | 0.51% | — |